| ²é¿´: 446 | »Ø¸´: 2 | |||
maximuswuxiͳæ (СÓÐÃûÆø)
|
[ÇóÖú]
¼¸¸ö¶Ì¾ä£¬Ó¢·ÖÐÇóÖú ÒÑÓÐ2È˲ÎÓë
|
|
1 Many of the trials could not be done at cancer centers [alone] or in a relationship with pharma¡£ 2 These newly assembled groups, including NRG Oncology, have been crafting their missions and identities in conjunction with the NCI. £¨NRG Oncology NCI£©¼òд²»Ó÷Ò룬Ö÷ÒªÊǶººÅºóÃæµÄÔõô·ÒëÇ¡µ±¡£ 3 The primary end point was a composite treatment failure and relapse, with noninferiority based on a margin of 6 percentage points and 90% confidence intervals.Õâ¾äÒ²ÊǶººÅºóÃæµÄÈçºÎ·Ò롣лл£¡ |
» ²ÂÄãϲ»¶
0856µ÷¼Á£¬ÊÇѧУ¾ÍÈ¥
ÒѾÓÐ6È˻ظ´
288Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
288Çóµ÷¼Á£¬Ò»Ö¾Ô¸»ªÄÏÀí¹¤´óѧ071005
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸Öйúº£Ñó´óѧ£¬ÉúÎïѧ£¬301·Ö£¬Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
294Çóµ÷¼Á²ÄÁÏÓ뻯¹¤×¨Ë¶
ÒѾÓÐ12È˻ظ´
0817 »¯Ñ§¹¤³Ì 299·ÖÇóµ÷¼Á ÓпÆÑоÀú ÓжþÇøÎÄÕÂ
ÒѾÓÐ13È˻ظ´
Áº³ÉΰÀÏʦ¿ÎÌâ×é»¶ÓÄãµÄ¼ÓÈë
ÒѾÓÐ11È˻ظ´
¸´ÊÔµ÷¼Á
ÒѾÓÐ6È˻ظ´
0703»¯Ñ§µ÷¼Á £¬Áù¼¶Òѹý£¬ÓпÆÑоÀú
ÒѾÓÐ11È˻ظ´
321Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
Çó·ÒëºÜ¶ÌµÄÒ»¸öС±êÌâ
ÒѾÓÐ3È˻ظ´
ÄÇЩ²»¿ÉÖ±ÒëµÄÓ¢Óï¶ÌÓÄãÖªµÀ¶àÉÙ£¿
ÒѾÓÐ18È˻ظ´
ÈÕ±¾ÎÄÏ×·Òë³ÉÓ¢ÎÄ
ÒѾÓÐ8È˻ظ´
Çë¸ßÈË·ÖÎöÒ»ÏÂÕâ¸ö¾ä×ÓµÄÓï·¨½á¹¹
ÒѾÓÐ65È˻ظ´
³æÓÑÃÇ£¬Äܲ»Äܰïæ·ÒëÒ»ÏÂÏÂÃæ¼¸¸ö¾ä×Ó
ÒѾÓÐ5È˻ظ´
Çó¼ì²é·Ò룬һƬӢÎÄÂÛÎÄÕªÒªÖв¿·Ö¾ä×Ó
ÒѾÓÐ4È˻ظ´
Çë°ïæ·ÒëÒ»¸ö¶Ì¾ä£¨ÖÐÎÄ·³ÉÓ¢ÎÄ£©£¡
ÒѾÓÐ1È˻ظ´
¡¾Ô´´¡¿GRE×÷Îı¸¿¼Ðĵü°ETSµç×ÓÆÀ·ÖÆ÷½âÎö
ÒѾÓÐ19È˻ظ´

hitoli
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 53 (³õÖÐÉú)
- ½ð±Ò: 2585.4
- ºì»¨: 3
- Ìû×Ó: 543
- ÔÚÏß: 151.6Сʱ
- ³æºÅ: 3165981
- ×¢²á: 2014-04-27
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
maximuswuxi: ½ð±Ò+5 2014-10-27 13:18:31
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
maximuswuxi: ½ð±Ò+5 2014-10-27 13:18:31
|
1.Ðí¶à²âÊÔûÄÜÔÚµ¥µ¥Ö×ÁöÖÐÐÄ»òÕßÔÚÓÐÒ©ÎïʱµÄÖ×ÁöÖÐÐÄʵÐС£ 2.ÕâЩеÄ×éºÏ»ùÍÅ£¬°üÀ¨NRG Oncology£¬ÔÚºÍNCIµÄżÁª¹ý³ÌÖУ¬Õ¹ÏÖÁËËüÃǵÄ×÷ÓÃÒÔ¼°ÌØÕ÷¡£ 3.ÔʼÖÕµãÊÇÖи´ºÏÁÆ·¨µÄʧ°ÜºÍºóÍË£¬Æä·ÇÁÓЧÐÔ»ùÓÚ¾à±ß½ç6¸ö°Ù·ÖµãÒÔ¼°90%µÄÖÃÐÅÇø¼ä¡£ Ï£Íû¶ÔÄãÓÐЩ°ïÖú¡£ |
2Â¥2014-10-26 18:13:15
qzwl11
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 7 (Ó×¶ùÔ°)
- ½ð±Ò: 208.8
- Ìû×Ó: 130
- ÔÚÏß: 104.9Сʱ
- ³æºÅ: 2534521
- ×¢²á: 2013-07-06
- ÐÔ±ð: GG
- רҵ: »·¾³¹¤³Ì
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
|
1Ðí¶àÊÔÑéÎÞ·¨µ¥¶ÀµØÔÚ°©Ö¢ÖÐÐÄ»òÕßÏà¹ØµÄÖÆÒ©¹«Ë¾ÖÐÍê³É¡£ 2ÕâЩÐÂ×齨µÄÍÅÌ壬°üÀ¨NRG OncologyÁªÃË£¬Ò»Ö±ÔÚÉè¼ÆËûÃǵÄÈÎÎñºÍÄ¿±êÖ¼ÔÚÓëÃÀ¹ú¹ú¼Ò°©Ö¢Ñо¿ËùµÄºÏ×÷¡£ 3ÔÚ·ÇÁÓÐÔµÄÖÃÐÅÇø¼ä·¶Î§ÔÚ6%~90%ʱ£¬Ö÷ÒªÖÕµãʼþÊÇÒ»ÖÖ¸´ºÏÁÆ·¨£¬ÎÞЧºÍ¸´·¢¡£ ËãÁË£¬²»ÊÇÒ»¸öרҵ£¬²»¾À½áÁË¡£¡£¡£ |

3Â¥2014-10-27 21:40:02













»Ø¸´´ËÂ¥